In our previous VRP-CEA study in patients with stage IV cancer,12 although viral replicon particle (VRP)-induced neutralizing antibodies were detected, we were nonetheless able to immunize repeatedly, increasing the humoral immune response. This evidence concerns the gene CEACAM5 and cancer.